Media
Read our latest media releases, news and stories to find out what we’re doing and where.
Centrient Pharmaceuticals appoints Rex Clements as Chief Executive Officer after Karl Rotthier decides to step down from the role
Centrient Pharmaceuticals, the global leader in the production and commercialisation of sustainable antibiotics, next-generation statins and anti-fungals, is announcing that Karl Rotthier has decided to step down as CEO after having built a highly successful company over the last ten years and managing a smooth transition to the new ownership under Bain Capital.
read more
Centrient Pharmaceuticals to boost statins manufacturing capacity
Doubling our API capacity to meet the growing demand
read more
Ready to respond
Our clear product recall procedures enable immediate, effective responses to issues.
read more
Highest priority to patient safety
Our pharmacovigilance system is helping to ensure safer use of medicines.
read more
Centrient Pharmaceuticals to boost statins manufacturing capacity
Doubling our API capacity to meet the growing demand for high-quality Atorvastatin and Rosuvastatin
read more
Penicillin laid the foundation for modern healthcare
With the discovery and large-scale production of antibiotics like penicillin, a wide range of bacterial infections were no longer considered life-threatening, driving a sharp increase in global life expectancy during the second half of the twentieth century.
read more
Driving transparency through serialisation
As one of the first generic pharmaceutical companies to have an IT system in place, we support our customers and partners with their own implementation processes.
read moreCentrient Pharmaceuticals Receives Gold Sustainability Rating from EcoVadis
read more
Building careers with Mexico’s refugees
As part of our effort to help people the communities where we work, we are helping to change the lives of refugees in Mexico.
read more
At Centrient, young professionals can make a difference
Rani Krisnamurthi, Product Marketing Manager at Centrient Pharmaceuticals in the Netherlands
read more
A sustainable supply chain for antibiotics
Combating antimicrobial resistance (AMR) means looking beyond our immediate horizons and working as part of the wider pharmaceutical value chain to effect change.
read more
STEM programme
We are working to raise awareness of antimicrobial resistance (AMR), and establish best practice in the regions where it’s needed most.
read more
media@centrient.com